WG
PNT

Winton Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Winton Group’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,056
Closed -$107K – 889
2023
Q3 		$107K Buy
+16,056
New +$133K 0.01% 715

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Winton Group's PNT Position: Q4 2023 in Review

Winton Group sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 16,056 shares — an estimated $107K sold.

Winton Group first reported a position in PNT in Q3 2023 and held it in 1 quarter. The position peaked at $107K in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Winton Group reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Winton Group sold 16,056 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $107K.
  • Winton Group first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Winton Group's POINT Biopharma Global Inc. Common Stock position peaked at $107K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Winton Group's 13F filing for Q4 2023, filed 12 Feb 2024.